Selected research
Industry Growth & Trends
Global Immune Cell Banking Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Immune Cell Banking Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Immune Cell Banking Service market include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL and Cordlife Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Immune Cell Banking Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Immune Cell Banking Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immune Cell Banking Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immune Cell Banking Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Immune Cell Banking Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Immune Cell Banking Service Market by Company
HealthBanks
BioLife Solutions
Sartorius
ThermoGenesis
Charles River
Biorep Technologies
Cryo-Cell International
CGT GLOBAL
Cordlife Group
Celularity
Boyalife
Beike Biotechnology
Forever Labs
Redermis
LifeCell International
VCANBIO
BGI Group
Shanghai Cell Therapy Group
Immune Cell Banking Service Segment by Type
Neonatal Immune Cell Storage
Adult Immune Cell Storage
Immune Cell Banking Service Segment by Application
Medical Scene
Non-medical Scene
Immune Cell Banking Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Cell Banking Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Cell Banking Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Cell Banking Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Immune Cell Banking Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Neonatal Immune Cell Storage
- Adult Immune Cell Storage
Applications
- Medical Scene
- Non-medical Scene
Companies covered
- HealthBanks
- BioLife Solutions
- Sartorius
- ThermoGenesis
- Charles River
- Biorep Technologies
- Cryo-Cell International
- CGT GLOBAL
- Cordlife Group
- Celularity
- Boyalife
- Beike Biotechnology
- Forever Labs
- Redermis
- LifeCell International
- VCANBIO
- BGI Group
- Shanghai Cell Therapy Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Immune Cell Banking Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Immune Cell Banking Service Market Size by Region (2021-2032)
- 1.4.1 Global Immune Cell Banking Service Market Size by Region (2021-2026)
- 1.4.2 Global Immune Cell Banking Service Market Size by Region (2027-2032)
- 1.5 Key Regions Immune Cell Banking Service Market Size (2021-2032)
- 1.5.1 North America Immune Cell Banking Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Immune Cell Banking Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Immune Cell Banking Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Immune Cell Banking Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Immune Cell Banking Service Market Size Growth Rate (2021-2032)
2 Immune Cell Banking Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Neonatal Immune Cell Storage
- 2.1.2 Adult Immune Cell Storage
- 2.2 Global Immune Cell Banking Service Market Size by Type
- 2.2.1 Global Immune Cell Banking Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Immune Cell Banking Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Immune Cell Banking Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Immune Cell Banking Service Market Size by Regions
- 2.3.1 North America Immune Cell Banking Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Immune Cell Banking Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Immune Cell Banking Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Immune Cell Banking Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Immune Cell Banking Service Market Size Breakdown by Type (2021-2026)
3 Immune Cell Banking Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Scene
- 3.1.2 Non-medical Scene
- 3.2 Global Immune Cell Banking Service Market Size by Application
- 3.2.1 Global Immune Cell Banking Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Immune Cell Banking Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Immune Cell Banking Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Immune Cell Banking Service Market Size by Regions
- 3.3.1 North America Immune Cell Banking Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Immune Cell Banking Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Immune Cell Banking Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Immune Cell Banking Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Immune Cell Banking Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Immune Cell Banking Service Industry Trends
- 4.2 Immune Cell Banking Service Industry Drivers
- 4.3 Immune Cell Banking Service Industry Opportunities and Challenges
- 4.4 Immune Cell Banking Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Immune Cell Banking Service Revenue (2021-2026)
- 5.2 Global Immune Cell Banking Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Immune Cell Banking Service Key Company Headquarters & Area Served
- 5.4 Global Immune Cell Banking Service Company, Product Type & Application
- 5.5 Global Immune Cell Banking Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Immune Cell Banking Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Immune Cell Banking Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Immune Cell Banking Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 HealthBanks
- 6.1.1 HealthBanks Company Information
- 6.1.2 HealthBanks Business Overview
- 6.1.3 HealthBanks Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 HealthBanks Immune Cell Banking Service Product Portfolio
- 6.1.5 HealthBanks Recent Developments
- 6.2 BioLife Solutions
- 6.2.1 BioLife Solutions Company Information
- 6.2.2 BioLife Solutions Business Overview
- 6.2.3 BioLife Solutions Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BioLife Solutions Immune Cell Banking Service Product Portfolio
- 6.2.5 BioLife Solutions Recent Developments
- 6.3 Sartorius
- 6.3.1 Sartorius Company Information
- 6.3.2 Sartorius Business Overview
- 6.3.3 Sartorius Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sartorius Immune Cell Banking Service Product Portfolio
- 6.3.5 Sartorius Recent Developments
- 6.4 ThermoGenesis
- 6.4.1 ThermoGenesis Company Information
- 6.4.2 ThermoGenesis Business Overview
- 6.4.3 ThermoGenesis Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ThermoGenesis Immune Cell Banking Service Product Portfolio
- 6.4.5 ThermoGenesis Recent Developments
- 6.5 Charles River
- 6.5.1 Charles River Company Information
- 6.5.2 Charles River Business Overview
- 6.5.3 Charles River Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Charles River Immune Cell Banking Service Product Portfolio
- 6.5.5 Charles River Recent Developments
- 6.6 Biorep Technologies
- 6.6.1 Biorep Technologies Company Information
- 6.6.2 Biorep Technologies Business Overview
- 6.6.3 Biorep Technologies Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Biorep Technologies Immune Cell Banking Service Product Portfolio
- 6.6.5 Biorep Technologies Recent Developments
- 6.7 Cryo-Cell International
- 6.7.1 Cryo-Cell International Company Information
- 6.7.2 Cryo-Cell International Business Overview
- 6.7.3 Cryo-Cell International Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Cryo-Cell International Immune Cell Banking Service Product Portfolio
- 6.7.5 Cryo-Cell International Recent Developments
- 6.8 CGT GLOBAL
- 6.8.1 CGT GLOBAL Company Information
- 6.8.2 CGT GLOBAL Business Overview
- 6.8.3 CGT GLOBAL Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 CGT GLOBAL Immune Cell Banking Service Product Portfolio
- 6.8.5 CGT GLOBAL Recent Developments
- 6.9 Cordlife Group
- 6.9.1 Cordlife Group Company Information
- 6.9.2 Cordlife Group Business Overview
- 6.9.3 Cordlife Group Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Cordlife Group Immune Cell Banking Service Product Portfolio
- 6.9.5 Cordlife Group Recent Developments
- 6.10 Celularity
- 6.10.1 Celularity Company Information
- 6.10.2 Celularity Business Overview
- 6.10.3 Celularity Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Celularity Immune Cell Banking Service Product Portfolio
- 6.10.5 Celularity Recent Developments
- 6.11 Boyalife
- 6.11.1 Boyalife Company Information
- 6.11.2 Boyalife Business Overview
- 6.11.3 Boyalife Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Boyalife Immune Cell Banking Service Product Portfolio
- 6.11.5 Boyalife Recent Developments
- 6.12 Beike Biotechnology
- 6.12.1 Beike Biotechnology Company Information
- 6.12.2 Beike Biotechnology Business Overview
- 6.12.3 Beike Biotechnology Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Beike Biotechnology Immune Cell Banking Service Product Portfolio
- 6.12.5 Beike Biotechnology Recent Developments
- 6.13 Forever Labs
- 6.13.1 Forever Labs Company Information
- 6.13.2 Forever Labs Business Overview
- 6.13.3 Forever Labs Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Forever Labs Immune Cell Banking Service Product Portfolio
- 6.13.5 Forever Labs Recent Developments
- 6.14 Redermis
- 6.14.1 Redermis Company Information
- 6.14.2 Redermis Business Overview
- 6.14.3 Redermis Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Redermis Immune Cell Banking Service Product Portfolio
- 6.14.5 Redermis Recent Developments
- 6.15 LifeCell International
- 6.15.1 LifeCell International Company Information
- 6.15.2 LifeCell International Business Overview
- 6.15.3 LifeCell International Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 LifeCell International Immune Cell Banking Service Product Portfolio
- 6.15.5 LifeCell International Recent Developments
- 6.16 VCANBIO
- 6.16.1 VCANBIO Company Information
- 6.16.2 VCANBIO Business Overview
- 6.16.3 VCANBIO Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 VCANBIO Immune Cell Banking Service Product Portfolio
- 6.16.5 VCANBIO Recent Developments
- 6.17 BGI Group
- 6.17.1 BGI Group Company Information
- 6.17.2 BGI Group Business Overview
- 6.17.3 BGI Group Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 BGI Group Immune Cell Banking Service Product Portfolio
- 6.17.5 BGI Group Recent Developments
- 6.18 Shanghai Cell Therapy Group
- 6.18.1 Shanghai Cell Therapy Group Company Information
- 6.18.2 Shanghai Cell Therapy Group Business Overview
- 6.18.3 Shanghai Cell Therapy Group Immune Cell Banking Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio
- 6.18.5 Shanghai Cell Therapy Group Recent Developments
7 North America
- 7.1 North America Immune Cell Banking Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Immune Cell Banking Service Market Size by Country (2021-2026)
- 7.3 North America Immune Cell Banking Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Immune Cell Banking Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Immune Cell Banking Service Market Size by Country (2021-2026)
- 8.3 Europe Immune Cell Banking Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Immune Cell Banking Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Immune Cell Banking Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Immune Cell Banking Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Immune Cell Banking Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Immune Cell Banking Service Market Size by Country (2021-2026)
- 10.3 South America Immune Cell Banking Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Immune Cell Banking Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Immune Cell Banking Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Immune Cell Banking Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst